Syndecan-4 as a Pathogenesis Factor and Therapeutic Target in Cancer
Cancer is an important cause of morbidity and mortality worldwide. Advances in research on the biology of cancer revealed alterations in several key pathways underlying tumorigenesis and provided molecular targets for developing new and improved existing therapies. Syndecan-4, a transmembrane hepara...
Main Authors: | Jessica Oyie Sousa Onyeisi, Carla Cristina Lopes, Martin Götte |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/11/4/503 |
Similar Items
-
Syndecans as modulators and potential pharmacological targets in cancer progression
by: Despoina eBarbouri, et al.
Published: (2014-02-01) -
Syndecan-3 in Inflammation and Angiogenesis
by: Samantha Arokiasamy, et al.
Published: (2020-01-01) -
The role of syndecan-1 in cellular signaling and its effects on heparan sulfate biosynthesis in mesenchymal tumors
by: Tünde eSzatmári, et al.
Published: (2013-12-01) -
Syndecan 4 Upregulation on Activated Langerhans Cells Counteracts Langerin Restriction to Facilitate Hepatitis C Virus Transmission
by: Bernadien M. Nijmeijer, et al.
Published: (2020-03-01) -
Research Note: Effect of selection for body weight on the adipogenic conversion of turkey myogenic satellite cells by Syndecan-4 and its covalently attached N-glycosylation chains
by: Sandra G. Velleman, et al.
Published: (2020-02-01)